Compounds > isoproterenol

isoproterenol and razoxane

isoproterenol has been researched along with razoxane in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (50.00)	18.2507
2000's	1 (25.00)	29.6817
2010's	1 (25.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M	1
D'Alessandro, N; Flandina, C; Rausa, L; Sanguedolce, R	1
Bast, A; Beems, DB; de Jong, J; Madhuizen, HT; van Acker, SA; van der Vijgh, WJ; Voest, EE	1
Filipský, T; Holečková, M; Hrdina, R; Macáková, K; Mladěnka, P; Palicka, V; Semecký, V; Vávrová, J; Zatloukalová, L	1

Other Studies

4 other study(ies) available for isoproterenol and razoxane

Article	Year
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors. Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21 Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship	2008
Ameliorative effects of ICRF-187 [(+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane] on the cardiotoxicity induced by doxorubicin or by isoproterenol in the mouse. Research communications in chemical pathology and pharmacology, 1990, Volume: 70, Issue:3 Topics: Animals; Doxorubicin; Female; Heart; Heart Atria; Injections, Intravenous; Isoproterenol; Mice; Premedication; Quality Assurance, Health Care; Razoxane	1990
Cardioprotective properties of O-(beta-hydroxyethyl)-rutosides in doxorubicin-pretreated BALB/c mice. Cancer research, 1993, Oct-01, Volume: 53, Issue:19 Topics: Animals; Body Weight; Colforsin; Doxorubicin; Drug Administration Schedule; Free Radical Scavengers; Heart; Heart Rate; Hydroxyethylrutoside; Injections, Intraperitoneal; Injections, Intravenous; Isoproterenol; Male; Mice; Mice, Inbred BALB C; Myocardial Contraction; Myocardium; Razoxane; Time Factors	1993
Dexrazoxane provided moderate protection in a catecholamine model of severe cardiotoxicity. Canadian journal of physiology and pharmacology, 2012, Volume: 90, Issue:4 Topics: Animals; Calcium; Cardiotonic Agents; Disease Models, Animal; Hemodynamics; Iron; Iron Chelating Agents; Isoproterenol; Male; Myocardial Infarction; Myocardium; Rats; Rats, Wistar; Razoxane	2012